UBS Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $599K | Sell |
173,090
-102,468
| -37% | -$355K | ﹤0.01% | 4710 |
|
|
2025
Q1 | $722K | Sell |
275,558
-67,688
| -20% | -$177K | ﹤0.01% | 4429 |
|
|
2024
Q4 | $1.41M | Buy |
343,246
+151,522
| +79% | +$624K | ﹤0.01% | 3976 |
|
|
2024
Q3 | $1.36M | Buy |
191,724
+2,404
| +1% | +$17K | ﹤0.01% | 3337 |
|
|
2024
Q2 | $1.23M | Sell |
189,320
-98,606
| -34% | -$643K | ﹤0.01% | 3223 |
|
|
2024
Q1 | $2.39M | Buy |
287,926
+101,627
| +55% | +$844K | ﹤0.01% | 2826 |
|
|
2023
Q4 | $2.05M | Buy |
186,299
+125,340
| +206% | +$1.38M | ﹤0.01% | 2831 |
|
|
2023
Q3 | $513K | Sell |
60,959
-133,738
| -69% | -$1.12M | ﹤0.01% | 3586 |
|
|
2023
Q2 | $2.45M | Buy |
194,697
+24,034
| +14% | +$302K | ﹤0.01% | 2531 |
|
|
2023
Q1 | $2.81M | Sell |
170,663
-92,437
| -35% | -$1.52M | ﹤0.01% | 2287 |
|
|
2022
Q4 | $3.93M | Buy |
263,100
+242,674
| +1,188% | +$3.63M | ﹤0.01% | 2027 |
|
|
2022
Q3 | $456K | Sell |
20,426
-44,207
| -68% | -$987K | ﹤0.01% | 3441 |
|
|
2022
Q2 | $1.08M | Sell |
64,633
-51,888
| -45% | -$869K | ﹤0.01% | 2831 |
|
|
2022
Q1 | $3.49M | Buy |
116,521
+22,283
| +24% | +$667K | ﹤0.01% | 2228 |
|
|
2021
Q4 | $2.89M | Buy |
94,238
+83,354
| +766% | +$2.56M | ﹤0.01% | 2577 |
|
|
2021
Q3 | $343K | Sell |
10,884
-19,727
| -64% | -$622K | ﹤0.01% | 3946 |
|
|
2021
Q2 | $1.12M | Sell |
30,611
-12,650
| -29% | -$463K | ﹤0.01% | 3169 |
|
|
2021
Q1 | $1.5M | Buy |
43,261
+34,849
| +414% | +$1.21M | ﹤0.01% | 3011 |
|
|
2020
Q4 | $350K | Buy |
8,412
+7,873
| +1,461% | +$328K | ﹤0.01% | 3921 |
|
|
2020
Q3 | $23K | Buy |
+539
| New | +$23K | ﹤0.01% | 5345 |
|